Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Enhua Hexin Pharmaceutical Marketing is a specialized subsidiary of Jiangsu Enhua Pharmaceutical, focusing on the commercialization and distribution of central nervous system (CNS) medications in China. The company manages a broad portfolio of products including anesthetics, analgesics, and psychiatric drugs. It plays a critical role in Enhua's market expansion strategy by leveraging a professional sales force and extensive hospital networks. The company is dedicated to providing high-quality medical solutions for neurological and mental health disorders. By integrating academic promotion with efficient supply chain management, Enhua Hexin supports the parent company's leadership in the domestic CNS market. It operates as the primary sales engine for one of China's most prominent CNS-focused pharmaceutical groups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 江苏恩华和信医药营销.